Login to Your Account

Other News To Note

Wednesday, August 22, 2012
• Nordic Bioscience A/S, of Copenhagen, Denmark, and Unigene Laboratories Inc., of Boonton, N.J., disclosed the preliminary selection of a lead compound for Type II diabetes under the firms' joint development vehicle (JDV).

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription